Fenofibrate reduces intestinal damage and improves intestinal recovery following intestinal ischemia–reperfusion injury in a rat

被引:0
作者
I. Sukhotnik
N. Nissimov
Y. Ben Shahar
D. Moati
N. Bitterman
Y. Pollak
D. Berkowitz
A. G. Coran
A. Bitterman
机构
[1] Technion-Israel Institute of Technology,Laboratory of Intestinal Adaptation and Recovery, The Bruce Rappaport Faculty of Medicine
[2] Bnai Zion Medical Center,Department of Pediatric Surgery B
[3] Carmel Medical Center,Department of Surgery
[4] Bnai Zion Medical Center,Department of Pediatric Gastroenterology
[5] University of Michigan Medical School,Section of Pediatric Surgery, C.S. Mott Children’s Hospital
来源
Pediatric Surgery International | 2016年 / 32卷
关键词
Intestine; Ischemia–reperfusion; Fenofibrate; Proliferation; Apoptosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1193 / 1200
页数:7
相关论文
共 162 条
[1]  
Deitch EA(1992)Multiple organ failure. Pathophysiology and potential future therapy Ann Surg 216 117-134
[2]  
Granger DN(1986)Ishemia reperfusion injury: role of oxygen-derived free radicals Acta Physiol Scand Suppl 548 47-56
[3]  
Hollwarth ME(2000)Pathophysiology of ischaemia–reperfusion injury J Pathol 190 255-266
[4]  
Park DA(1996)Arachidonic acid metabolism in intestinal hypothermic preservation injury Cryobiology 33 404-412
[5]  
Carden DL(1997)Ischemia/reperfusion-induced microvascular dysfunction: role of oxidants and lipid mediators Am J Physiol 272 H2976-H2982
[6]  
Granger DN(2001)The role of tumor necrosis factor-alpha and interleukin-1beta in ischemia–reperfusion injury of the rat small intestine J Surg Res 99 134-141
[7]  
Mangino MJ(1991)Involvement of neutrophils in postischaemic damage to the small intestine Gut 32 905-1112
[8]  
Mangino JE(2000)Phagocytic and intestinal endothelial and epithelial barrier function during the early stage of small intestinal ischemia and reperfusion injury Shock 13 209-216
[9]  
Murphy MK(1992)Endotoxin after gut ischemia/reperfusion causes irreversible lung injury J Surg Res 52 656-662
[10]  
Anderson CB(1999)Medical significance of peroxisome proliferator-activated receptors Lancet 354 141-148